Serafeim Chrysikos

562 total citations
24 papers, 255 citations indexed

About

Serafeim Chrysikos is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Epidemiology. According to data from OpenAlex, Serafeim Chrysikos has authored 24 papers receiving a total of 255 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pulmonary and Respiratory Medicine, 5 papers in Physiology and 4 papers in Epidemiology. Recurrent topics in Serafeim Chrysikos's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (12 papers), Lung Cancer Diagnosis and Treatment (5 papers) and Sarcoidosis and Beryllium Toxicity Research (4 papers). Serafeim Chrysikos is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (12 papers), Lung Cancer Diagnosis and Treatment (5 papers) and Sarcoidosis and Beryllium Toxicity Research (4 papers). Serafeim Chrysikos collaborates with scholars based in Greece, Kuwait and United States. Serafeim Chrysikos's co-authors include Τheodoros Karampitsakos, Argyrios Tzouvelekis, Katerina Dimakou, Demosthenes Bouros, Vasilios Tzilas, Ουρανία Παπαϊωάννου, Νikolaos Koulouris, Evangelos Bouros, Christina Triantafillidou and Paschalis Ntolios and has published in prestigious journals such as CHEST Journal, Frontiers in Oncology and International Journal of Clinical Practice.

In The Last Decade

Serafeim Chrysikos

23 papers receiving 251 citations

Peers

Countries citing papers authored by Serafeim Chrysikos

Since Specialization

Citations

This map shows the geographic impact of Serafeim Chrysikos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Serafeim Chrysikos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Serafeim Chrysikos more than expected).

Fields of papers citing papers by Serafeim Chrysikos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Serafeim Chrysikos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Serafeim Chrysikos. The network helps show where Serafeim Chrysikos may publish in the future.

Co-authorship network of co-authors of Serafeim Chrysikos

This figure shows the co-authorship network connecting the top 25 collaborators of Serafeim Chrysikos. A scholar is included among the top collaborators of Serafeim Chrysikos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Serafeim Chrysikos. Serafeim Chrysikos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Comparison of effectiveness and safety between baricitinib and tocilizumab in severe COVID-19: a retrospective study 2025 ·Expert Review of Respiratory Medicine ·Ioannis Tomos, (unknown), (unknown), Serafeim Chrysikos, (unknown), Κonstantinos Thomas, Georgios Hillas, (unknown), Anastasia Antoniadou, Dimitra Kavatha, Katerina Dimakou	0
2	Value of 18-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) in the differential diagnosis of sarcoidosis and lung cancer with lymph node metastasis: a retrospective study 2022 ·Translational Lung Cancer Research ·(unknown), Xin Xu, Serafeim Chrysikos, Mengmeng Zhao, Ying Zhou	6
3	Predictors of Mortality in Tocilizumab-Treated Severe COVID-19 2022 ·Vaccines ·(unknown), Serafeim Chrysikos, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Katerina Dimakou, Ιlias Papanikolaou	3
4	Diagnostic Accuracy of Multiple D-Dimer Cutoff Thresholds and Other Clinically Applicable Biomarkers for the Detection and Radiographic Evaluation of Pulmonary Embolism 2022 ·Advances in respiratory medicine ·Serafeim Chrysikos, Ουρανία Παπαϊωάννου, Τheodoros Karampitsakos, (unknown), (unknown), (unknown), (unknown), Georgios Hillas, Argyrios Tzouvelekis, Loukas Thanos, Katerina Dimakou	3
5	Differential expression of PD-1/PD-L1 axis in mediastinal lymph nodes of experimental and human lung fibrosis 2022 ·Τheodoros Karampitsakos, Serafeim Chrysikos, (unknown), (unknown), Ουρανία Παπαϊωάννου, (unknown), (unknown), Evangelos Bouros, Nektarios Anagnostopoulos, (unknown), Effrosyni D. Manali, Spyridon Papiris, Demosthenes Bouros, Petros Bakakos, Vassilis Aidinis, Αrgyris Τzouvelekis	1
6	Safety and Effectiveness of Mycophenolate Mofetil in Interstitial Lung Diseases: Insights from a Machine Learning Radiographic Model 2021 ·Respiration ·Τheodoros Karampitsakos, Christina Kalogeropoulou, Vasilios Tzilas, Ουρανία Παπαϊωάννου, Alexandra Kazantzi, Evangelia Koukaki, (unknown), Evangelos Bouros, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Serafeim Chrysikos, (unknown), Fotios Sampsonas, Demosthenes Bouros, Argyrios Tzouvelekis	9
7	Differential expression of PD-1/PD-L1 axis and CD4/CD8 ratio in mediastinal lymph nodes of patients with idiopathic pulmonary fibrosis and lung cancer 2021 ·Τheodoros Karampitsakos, Serafeim Chrysikos, Ioannis Vamvakaris, Ουρανία Παπαϊωάννου, Evangelos Bouros, Vasilios Tzilas, (unknown), (unknown), Effrosyni D. Manali, Spyridon Papiris, Demosthenes Bouros, Petros Bakakos, Αrgyris Τzouvelekis	1
8	A 52-Year-Old Man Presented With Cough, Chest Pain, and a Mass in the Right Lung 2020 ·CHEST Journal ·Serafeim Chrysikos, Ουρανία Παπαϊωάννου, (unknown), Τheodoros Karampitsakos, Ioannis Vamvakaris, Argyrios Tzouvelekis, Katerina Dimakou	1
9	Clinical utility of thoracic endosonography (EBUS/EUS-b) in mediastinal staging of patients with non-small cell lung cancer: comparison with integrated PET/CT—a real-life prospective study in Greece 2020 ·Journal of Thoracic Disease ·Serafeim Chrysikos, Ioannis Gkiozos, Katerina Dimakou, Εleftherios Ζervas, Τheodoros Karampitsakos, (unknown), Argyrios Tzouvelekis, Κonstantinos Samitas, Mina Gaga, Νikolaos Koulouris, Ioannis Vasileiadis, Konstantinos Syrigos	8
10	Increased monocyte count and red cell distribution width represent negative prognostic markers in patients with Hypersensitivity Pneumonitis 2020 ·Τheodoros Karampitsakos, Evangelos Bouros, Ουρανία Παπαϊωάννου, (unknown), (unknown), (unknown), Serafeim Chrysikos, Nektarios Anagnostopoulos, (unknown), Evangelia Koukaki, (unknown), Vasilios Tzilas, Katerina Dimakou, Demosthenes Bouros, Argyrios Tzouvelekis	1
11	Thoracic endosonography (EBUS/EUS‐b) in the diagnosis of different intrathoracic diseases: A 4‐year experience at a single‐centre in Greece 2020 ·International Journal of Clinical Practice ·Serafeim Chrysikos, Τheodoros Karampitsakos, Εleftherios Ζervas, (unknown), Ουρανία Παπαϊωάννου, Argyrios Tzouvelekis, (unknown), Katerina Dimakou	2
12	The role of increased red cell distribution width as a negative prognostic marker in patients with COPD 2019 ·Pulmonary Pharmacology & Therapeutics ·Τheodoros Karampitsakos, Katerina Dimakou, Ουρανία Παπαϊωάννου, Serafeim Chrysikos, (unknown), Demosthenes Bouros, Argyrios Tzouvelekis, Georgios Hillas	24
13	Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration/Biopsy (EBUS-TBNA/B): 5-Year Experience of a Referral Center in Greece 2019 ·Mina Gaga, Serafeim Chrysikos, Clementine Bostantzoglou, (unknown), (unknown), (unknown), (unknown), Εleftherios Ζervas	2
14	Safety and efficacy of nintedanib in idiopathic pulmonary fibrosis: A real-life observational study in Greece 2018 ·Pulmonary Pharmacology & Therapeutics ·Argyrios Tzouvelekis, Τheodoros Karampitsakos, (unknown), (unknown), (unknown), Nektarios Anagnostopoulos, Paschalis Ntolios, Vasilios Tzilas, Evangelos Bouros, Paschalis Steiropoulos, Serafeim Chrysikos, Katerina Dimakou, Νikolaos Koulouris, Demosthenes Bouros	48
15	Pulmonary hypertension in patients with interstitial lung disease 2018 ·Pulmonary Pharmacology & Therapeutics ·Τheodoros Karampitsakos, Argyrios Tzouvelekis, Serafeim Chrysikos, Demosthenes Bouros, Iraklis Tsangaris, Wassim H. Fares	20
16	Endobronchial Metastasis from Renal Cell Carcinoma as a Reason for Recurrent Pulmonary Infections 2018 ·Advances in respiratory medicine ·Serafeim Chrysikos, Τheodoros Karampitsakos, Argyrios Tzouvelekis, Katerina Dimakou	5
17	A Rare Case of Primary Intrapulmonary Neurilemmoma Diagnosed in a 43-Year-Old Asymptomatic Man with a Well-defined Intrapulmonary Mass 2018 ·Frontiers in Oncology ·Serafeim Chrysikos, (unknown), Christina Triantafillidou, Τheodoros Karampitsakos, Argyrios Tzouvelekis, (unknown), (unknown), Marios Konstantinou, (unknown), Demosthenes Bouros, Katerina Dimakou	4
18	Metabolic Disorders in Chronic Lung Diseases 2018 ·Frontiers in Medicine ·Ουρανία Παπαϊωάννου, Τheodoros Karampitsakos, (unknown), Serafeim Chrysikos, Nikos Xylourgidis, Vasilios Tzilas, Demosthenes Bouros, Vassilis Aidinis, Argyrios Tzouvelekis	31
19	Longitudinal “Real-World” Outcomes of Pirfenidone in Idiopathic Pulmonary Fibrosis in Greece 2017 ·Frontiers in Medicine ·Argyrios Tzouvelekis, Τheodoros Karampitsakos, Paschalis Ntolios, Vasilios Tzilas, Evangelos Bouros, (unknown), (unknown), Nektarios Anagnostopoulos, (unknown), Paschalis Steiropoulos, Katerina Dimakou, Serafeim Chrysikos, Νikolaos Koulouris, Demosthenes Bouros	35
20	Investigation of bronchiectasis in severe uncontrolled asthma 2017 ·The Clinical Respiratory Journal ·Katerina Dimakou, (unknown), Michail Toumbis, (unknown), Serafeim Chrysikos, Loukas Thanos, Christina Triantafillidou	40

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact